Advertisement
U.S. Markets open in 7 hrs 1 min

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
10.30-0.39 (-3.65%)
At close: 04:00PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
829.941
1,613
1,422
2,916
3,613
-
Cost of Revenue
-
-
-
-
-
230.097
Gross Profit
-
-
-
-
-
2,533
Operating Expense
12,035
11,894
21,942
18,422
15,856
-
Operating Income
-11,205
-10,281
-20,520
-15,506
-12,243
-
Net Non Operating Interest Income Expense
14.06
42.357
-19.646
-57.69
-34.197
-
Other Income Expense
-665.952
-317.285
-264.36
211.693
-581.128
-
Pretax Income
-11,857
-10,556
-20,804
-15,352
-12,859
-
Tax Provision
0
0
0
0
0
-
Net Income Common Stockholders
4,318
-10,556
-20,804
-15,352
-12,859
-
Diluted NI Available to Com Stockholders
4,318
-10,556
-20,804
-15,352
-12,859
-
Basic EPS
-18.00
-16.80
-55.20
-54.00
-57.60
-
Diluted EPS
-18.00
-16.80
-55.20
-54.00
-57.60
-
Basic Average Shares
558.17
619.23
376.541
284.331
222.348
-
Diluted Average Shares
558.17
619.23
376.541
284.331
222.348
-
Total Operating Income as Reported
-11,205
-10,281
-20,520
-15,506
-12,243
-
Rent Expense Supplemental
-
35.567
47.283
37.512
12
-
Total Expenses
12,035
11,894
21,942
18,422
15,856
-
Net Income from Continuing & Discontinued Operation
4,318
-10,556
-20,804
-15,352
-12,859
-
Normalized Income
-11,722
-10,239
-20,540
-15,564
-12,277
-
Interest Income
35.867
63.964
29.251
5.322
35.305
-
Interest Expense
21.807
21.607
48.897
63.012
69.502
-
Net Interest Income
14.06
42.357
-19.646
-57.69
-34.197
-
EBIT
-11,835
-10,535
-20,755
-15,289
-12,789
-
EBITDA
-11,420
-10,229
-20,432
-14,941
-12,410
-
Reconciled Cost of Revenue
-
-
-
-
-
230.097
Reconciled Depreciation
337.508
305.952
323.144
347.613
378.754
-
Net Income from Continuing Operation Net Minority Interest
-11,857
-10,556
-20,804
-15,352
-12,859
-
Total Unusual Items Excluding Goodwill
-135.203
-317.285
-264.36
211.693
-581.128
-
Total Unusual Items
-135.203
-317.285
-264.36
211.693
-581.128
-
Normalized EBITDA
-11,284
-9,911
-20,168
-15,153
-11,829
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-